Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atherosclerosis Monitoring and Atherogenicity Reduction Study

NCT01734707 is registered in ClinicalTrials.gov with Institute for Atherosclerosis Research, Russia as lead sponsor.

NCT NCT01734707
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01734707 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atherosclerosis Monitoring and Atherogenicity Reduction Study
Lead sponsor
Institute for Atherosclerosis Research, Russia
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2004
Completion date
October 31, 2005
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carotid atherosclerosis